A Double-Blind Placebo Controlled Therapeutic Trial on Patients with Stable Non-Segmental Vitiligo Using a Specially Formulated Reducing Antioxidant Gel Enhanced by Excimer Light Exposure
Background: Vitiligo is a common skin condition that causes patches of lightening that affect 0.2 to 0.5 percent of the world's population. It is marked by chalky white macules because melanocytes are being selectively lost. Several ideas have been put forward about what causes the disease, suc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Al-Azhar University, Faculty of Medicine (Damietta)
2023-09-01
|
Series: | International Journal of Medical Arts |
Subjects: | |
Online Access: | https://ijma.journals.ekb.eg/article_326663_9bf715912fffadabc38b1b1604d11cac.pdf |